Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 121 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1201 10.0 months Adult T-cell leukemia lymphoma 3 Biologic therapy
Chemotherapy
Hormone
King's College Hospital United Kingdom 12/2011
Treatment Details: Patients: This phase II study involved 15 adult T-cell leukemia lymphoma (ATLL) patients with a median age of 48 years; 2 were male. Treatment: Patients were treated with a combination
 
1202 10.0 months Ovarian cancer 3 Chemotherapy
Mansoura University Egypt 1/2012
Treatment Details: Patients: This phase 2 study involved 40 ovarian cancer patients who had received previous platinum-taxane chemotherapy. The median patient age was 61 years. Treatment: Patients were t
 
1203 10.0 months iffuse large B-cell lymphoma 4 Biologic therapy
Chemotherapy
Hormone
Weill Cornell Medical College United States 8/2012
Treatment Details: Patients: This study involved 15 relapsed or refractory diffuse large B-cell lymphoma patients who had previously received chemotherapy. The median patient age was 64 years; no gender info
 
1204 10.0 months Advanced melanoma 3 Immunotherapy
University of Minnesota United States 12/2012
Treatment Details: Patients: This phase 2 study involved advanced melanoma patients who were divided into two separate treatment groups. There were 11 patients in group A and 10 patients in group B. Age and
 
1205 10.0 months Metastatic colorectal cancer 5 Biologic therapy
The Queen Elizabeth Hospital and University of Adelaide Australia 4/2014
Treatment Details: Patients: This phase 3 study involved previously treated metastatic colorectal cancer patients with wild-type KRAS exon 2 cancer who were divided into two separate treatment groups. Group
 
1206 10.0 months Metastatic, castration-resistant prostate cancer 5 Radiation
Mayo Clinic United States 5/2014
Treatment Details: Patients: This phase 3 study involved metastatic castration-resistant prostate cancer patients with bone metastases who had received prior treatment with docetaxel. Patients were divided i
 
1207 10.0 months Metastatic Bladder Cancer 4 Chemotherapy
Ramón y Cajal University Hospital Spain 10/2014
Treatment Details: Patients: This study involved 102 patients with metastatic transitional cell carcinoma of the urothelial tract after who had previously received platinum-based chemotherapy. The median pat
 
1208 10.0 months NSCLC 4 Chemotherapy
Chungnam National University Korea 3/2015
Treatment Details: Patients: This study involved 35 previously treated advanced non-small cell lung cancer patients. The median patient age was 63 years and 27 were male. Treatment: Patients received che
 
1209 9.9 months Advanced NSCLC 5 Biologic therapy
Chemotherapy
University of Ioannina School of Medicine Greece 10/2014
Treatment Details: Patients: This phase 2 study involved 25 advanced non-small cell lung cancer patients. The median patient age was 64 years and 76% were male. Treatment: Patients received biologic ther
 
1210 9.9 months Metastatic melanoma 5 Biologic therapy
Chemotherapy
Newcastle University United Kingdom 5/2013
Treatment Details: Patients: This phase 2 study involved 46 advanced metastatic melanoma patients. The average patient age was 51.5 years (range of 19-82) and 52% were male. Treatment: Patients were trea
 
Page 121 of 187  | Previous Page  | Next Page